血管质量倡议静脉曲张登记研究首10个月结果
结果显示轴向反流以腔内热消融为主(89.1%),团块状曲张以点状剥脱为主(84.8%),术后VCSS和患者报告结局均显著改善。
要点
- 轴向反流首选腔内热消融(89.1%),其中射频消融占55.2%、激光消融占33.9%。
- 团块状曲张多在小腿(89.7%),常与主干反流同期处理(76%),以点状剥脱为主(84.8%)。
- 术后VCSS平均改善4.68分,患者报告结局总分平均改善10.75分,均具统计学显著性。
核心结论
- 现代静脉曲张手术以腔内热消融处理轴向反流、点状剥脱处理团块状曲张为特征,术后VCSS和患者报告结局均显著改善。
主要发现
- 患者中女性占71.5%、白人占78.3%,31.2%有既往静脉曲张治疗史。
- 反流最常见于大隐静脉(74.4%),31%患者合并深静脉反流,左右肢受累均等。
- 轴向反流腔内治疗占89.1%,其中射频消融55.2%、腔内激光消融33.9%。
- 团块状曲张76%(n=488)与主干反流同期处理,78.1%在诊室完成,89.7%位于小腿,84.8%接受点状剥脱。
- 术后VCSS平均改善4.68±3.35(n=719,P<.001),患者报告结局总分平均改善10.75±6.94(n=607,P<.001)。
关键数值与推荐
- 术后VCSS由术前平均9.39±3.87降至平均4.71±3.83(n=719,P<.001)。
- 患者报告结局总分由术前平均16.48±6.23降至平均5.73±5.80(n=607,P<.001)。
临床怎么用
- 登记数据可用于监测静脉曲张治疗后的VCSS和患者报告结局变化,支持以腔内热消融联合点状剥脱为主的治疗模式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Vascular Quality Initiative Varicose Vein Registry (VQI VVR) represents a new Patient Safety Organization database launched in January 2015 as a collaborative effort between the American Venous Forum and the Society for Vascular Surgery. This study was undertaken to identify real-world trends among treatment choices and outcomes of varicose vein patients. METHODS: Registry data prospectively captured anatomic, procedural, and outcome data for patients with C2 or more severe disease undergoing intervention for venous varicosities from January to November 2015. Univariate descriptive statistics of demographic and procedural data was performed. Preprocedural and postprocedural comparisons were performed with t-test or χ2 analysis as appropriate. RESULTS: In total, 2661 veins in 1803 limbs of 1406 patients were treated for varicose vein disease. The majority of patients were female (71.5%) and white (78.3%). Previous varicose vein treatment had been undertaken by 31.2%. The most common site of reflux was the great saphenous vein in 74.4%, with 31% of patients having coexisting deep venous reflux. The right and left extremities were affected equally. Endovenous treatment of axial reflux was the preferred treatment in 89.1%, divided largely between radiofrequency ablation (55.2%) and endovenous laser ablation (33.9%). Clusters were often treated concomitantly with truncal reflux (n = 488 [76%]). The majority of cluster treatments were performed in an office-based setting (78.1%). The majority of clusters were located at the calf (89.7%) and treated with stab phlebectomy (84.8%). For all patients undergoing intervention for varicose veins, Venous Clinical Severity Score (VCSS) improved on average 4.68 ± 3.35 (n = 719; P < .001) postoperatively from a mean preoperative VCSS of 9.39 ± 3.87 to a mean postoperative VCSS of 4.71 ± 3.83. Improvements were seen in patient-reported outcomes (PROs) of heaviness, achiness, throbbing, swelling, itching, appearance, and work impact (total score change, 10.75 ± 6.94; n = 607; P < .001) from a mean preoperative PRO score of 16.48 ± 6.23 to a mean postoperative PRO score of 5.73 ± 5.80. CONCLUSIONS: The VQI VVR provides detailed assessment of varicose vein interventions and is useful for monitoring of changes after treatment. Modern-day varicose vein surgery is characterized by predominantly endovenous treatment of axial vein reflux, phlebectomy of clusters, and substantial improvements in both VCSS and PROs.
引用
- Obi AT, Sutzko DC, Almeida JI, et al. First 10-month results of the Vascular Quality Initiative Varicose Vein Registry. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28411696. doi:10.1016/j.jvsv.2016.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。